ClinicalTrials.Veeva

Menu

Immediate Breast Reconstruction's Increasing (IBRI)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Breast Cancer
Breast Reconstruction

Treatments

Other: To analyze variations of number of patients eligibles to IBR
Other: Comparison of complications between mastectomies with IBR and mastectomies without IBR

Study type

Observational

Funder types

Other

Identifiers

NCT04888351
69HCL21_0145

Details and patient eligibility

About

Mastectomy in breast cancer is still a way of treatment. Nowadays, the goal is to improve reconstruction's technicals. Immediate Breast Reconstruction (IBR) is one of them, largely used in United States but less in France. However, IGR (Insitut Gustave Roussey) in Paris just wrote a new protocole wich allows more IBR by including more patients.

This study aims to compare complications in 2 groups: mastectomies followed by IBR and mastectomies without IBR. The second goal will try to estimate the proportion of eligible's patients to IBR, and to analyse their surgicals and oncologicals risk factors

Enrollment

215 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years
  • Breast cancer
  • Mastectomy
  • Hopital de la Croix-Rousse
  • January 2016 and January 2020

Exclusion criteria

  • Prophylactic mastectomy
  • Male gender

Trial design

215 participants in 2 patient groups

Mastectomies with IBR
Description:
Every women\>18 years who underwent mastectomies followed by IBR (prothesis, latissimus dorsi flap, lipofeeling, isolated or combined) for breast cancer in Hôpital de la Croix-Rousse between January 2016 and January 2020
Treatment:
Other: To analyze variations of number of patients eligibles to IBR
Other: Comparison of complications between mastectomies with IBR and mastectomies without IBR
Mastectomies without IBR
Description:
Every women\>18 years who underwent mastectomies for breast cancer followed by delayed reconstructions (prothesis, latissimus dorsi flap, lipofeeling, isolated or combined) or no reconstructions between January 2016 and January 2020 in Hôpital de la Croix-Rousse
Treatment:
Other: To analyze variations of number of patients eligibles to IBR
Other: Comparison of complications between mastectomies with IBR and mastectomies without IBR

Trial contacts and locations

1

Loading...

Central trial contact

Marion CORTET, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems